|
Volumn 9, Issue 3, 2005, Pages 332-338
|
Cetuximab: adverse event profile and recommendations for toxicity management.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CETUXIMAB;
MONOCLONAL ANTIBODY;
ACNE;
DRUG ERUPTION;
DRUG HYPERSENSITIVITY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
NAIL DISEASE;
PRACTICE GUIDELINE;
REVIEW;
ACNEIFORM ERUPTIONS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
DRUG ERUPTIONS;
DRUG HYPERSENSITIVITY;
HUMANS;
INFUSIONS, INTRAVENOUS;
NAIL DISEASES;
PRACTICE GUIDELINES;
MLCS;
MLOWN;
|
EID: 21744437946
PISSN: 10921095
EISSN: None
Source Type: Journal
DOI: 10.1188/05.cjon.332-338 Document Type: Review |
Times cited : (44)
|
References (26)
|